Bailard’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Hold
27,500
0.01% 686
2026
Q1
$298K Buy
+27,500
New +$235K 0.01% 599
2025
Q3
Sell
-32,600
Closed -$193K 860
2025
Q2
$193K Buy
32,600
+14,881
+84% +$89.6K ﹤0.01% 725
2025
Q1
$146K Sell
17,719
-9,551
-35% -$80.1K ﹤0.01% 706
2024
Q4
$225K Buy
+27,270
New +$219K 0.01% 662
2024
Q2
Sell
-17,600
Closed -$210K 797
2024
Q1
$210K Sell
17,600
-13,398
-43% -$149K 0.01% 680
2023
Q4
$335K Sell
30,998
-8,200
-21% -$99.7K 0.01% 535
2023
Q3
$543K Sell
39,198
-11,500
-23% -$168K 0.02% 399
2023
Q2
$607K Buy
+50,698
New +$572K 0.02% 351
2020
Q4
Sell
-21,600
Closed -$62K 667
2020
Q3
$62K Buy
+21,600
New +$79.4K ﹤0.01% 540

Other funds holding PTEN

Bailard's PTEN Position: Q2 2026 in Review

Bailard held its Patterson-UTI (PTEN) position steady in Q2 2026 at 27,500 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #686.

Bailard first reported a position in PTEN in Q3 2020 and has held it in 10 quarters since. The position peaked at $607K in Q2 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Bailard held 27,500 shares of Patterson-UTI worth $252K as of Q2 2026.
  • Bailard left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up 0.01% of Bailard's portfolio in Q2 2026, its #686 holding.
  • Bailard first reported a position in Patterson-UTI in Q3 2020 and has held it in 10 quarters since.
  • Bailard's Patterson-UTI position peaked at $607K in Q2 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.